Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Parent Artery Reconstruction for Cerebral Aneurysms Using a Novel Flow Diverter With Surface Modification

NCT: NCT05774782 · COMPLETED

NCT IDNCT05774782
StatusCOMPLETED
Start Date2023-03-27
Completion2024-08-30
SponsorSinomed Neurovita Technology Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The primary objective of this trial is to evaluate the safety and efficacy of the cerebral flow diverter in the endovascular treatment of wide-necked cerebral aneurysms

Frequently Asked Questions

What is Parent Artery Reconstruction for Cerebral Aneurysms Using a Novel Flow Diverter With Surface Modification?

Parent Artery Reconstruction for Cerebral Aneurysms Using a Novel Flow Diverter With Surface Modification is a clinical trial registered under NCT05774782. Current status: COMPLETED.

What is the status of NCT05774782?

The current status of NCT05774782 (Parent Artery Reconstruction for Cerebral Aneurysms Using a Novel Flow Diverter With Surface Modification) is: COMPLETED.

When did Parent Artery Reconstruction for Cerebral Aneurysms Using a Novel Flow Diverter With Surface Modification start?

Parent Artery Reconstruction for Cerebral Aneurysms Using a Novel Flow Diverter With Surface Modification started on 2023-03-27.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.